Selected article for: "adverse event and case report"

Author: Fragoso, Yara D; Gomes, Sidney; Gonçalves, Marcus Vinicius M; Junior, Euldes Mendes; de Oliveira, Bianca Etelvina S; Rocha, Cristiane Franklin; Cruz dos Santos, Gutemberg A; Tauil, Carlos Bernardo; Araujo, Raquel Vassao; Peron, Jean Pierre S
Title: New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19
  • Cord-id: 4f40ctvu
  • Document date: 2021_10_13
  • ID: 4f40ctvu
    Snippet: We report on nine patients (eight cases of MS and one case of NMOSD) who presented a disease relapse in close temporal association with their first AZD1222 vaccination dose against COVID-19. These patients had been stable for a median period of six years, with no evidence of disease activity and no change in their medication. After a median of 13 days (7 to 25 days) from vaccination, they developed a new relapse with increased disability and new lesions on magnetic resonance imaging. Although ex
    Document: We report on nine patients (eight cases of MS and one case of NMOSD) who presented a disease relapse in close temporal association with their first AZD1222 vaccination dose against COVID-19. These patients had been stable for a median period of six years, with no evidence of disease activity and no change in their medication. After a median of 13 days (7 to 25 days) from vaccination, they developed a new relapse with increased disability and new lesions on magnetic resonance imaging. Although exceedingly rare, this might be an adverse event of AZD1222.

    Search related documents:
    Co phrase search for related documents